Critical issues in gene therapy for neurologic disease

Human Gene Therapy
Gary HsichXandra O Breakefield

Abstract

Gene therapy for the nervous system is a newly emerging field with special issues related to modes of delivery, potential toxicity, and realistic expectations for treatment of this vital and highly complex tissue. This review focuses on the potential for gene delivery to the brain, as well as possible risks and benefits of these procedures. This includes discussion of appropriate vectors, such as adeno-associated virus, lentivirus, gutless adenovirus, and herpes simplex virus hybrid amplicons, and cell vehicles, such as neuroprogenitor cells. Routes of delivery for focal and global diseases are enumerated, including use of migratory cells, facilitation of vascular delivery across the blood-brain barrier, cerebrospinal fluid delivery, and convection injection. Attention is given to examples of diseases falling into different etiologic types: metabolic deficiency states, including Canavan disease and lysosomal storage disorders; and degenerative conditions, including Parkinson's disease and other neurodegenerative conditions.

References

Jan 1, 1977·Archives of Neurology·P L McGeerJ S Suzuki
Dec 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·L M MessinaJ C Stanley
Jan 1, 1991·Annual Review of Biochemistry·E F Neufeld
Nov 1, 1990·Journal of Neuroscience Research·M P ShortR L Martuza
Mar 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·N W BartonR O Brady
Jan 1, 1989·Neuroscience and Biobehavioral Reviews·D L Birken, W H Oldendorf
Jan 1, 1986·Experimental Brain Research·W J FreedH M Geller
Feb 1, 1988·American Journal of Medical Genetics·R MatalonJ Casanova
Aug 15, 1986·Clinica Chimica Acta; International Journal of Clinical Chemistry·E A KvittingenE Jellum
Jul 10, 1970·Science·E F Neufeld, J C Fratantoni
Jul 1, 1968·Physiological Reviews·R Levi-Montalcini, P U Angeletti
Jun 1, 1994·Experimental Neurology·R AntonR H Edwards
Oct 10, 1995·Proceedings of the National Academy of Sciences of the United States of America·G NilaverE A Neuwelt
Jun 1, 1995·Neuroscience·A P ByrnesH M Charlton
Dec 20, 1994·Proceedings of the National Academy of Sciences of the United States of America·R M ShullE F Neufeld
Jan 1, 1995·Journal of Neuropathology and Experimental Neurology·H B Sarnat
Nov 1, 1994·Journal of Virology·J R LokensgardL T Feldman
Jun 21, 1994·Proceedings of the National Academy of Sciences of the United States of America·M D WeitzmanR A Owens
Sep 1, 1994·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·T Inamura, K L Black
Sep 2, 1994·Gene·J PevsnerR H Scheller

❮ Previous
Next ❯

Citations

Sep 11, 2002·The Journal of Gene Medicine·Catherine BarjotJeffrey S Chamberlain
Aug 24, 2004·Cell and Tissue Research·O Eberhardt, J B Schulz
Sep 5, 2003·Physiology & Behavior·Robert M Sapolsky
Apr 2, 2003·Pharmacology & Therapeutics·M G CastroP R Lowenstein
May 6, 2005·Human Gene Therapy·Sandra M KleinClive N Svendsen
Oct 6, 2006·Current Opinion in Anaesthesiology·Michel Pohl, Alice Meunier
May 7, 2004·Neuroreport·Ryosei MinodaYehoash Raphael
Sep 27, 2006·Neuroreport·Zhiren ZhangHermann J Schluesener
Dec 15, 2010·International Archives of Medicine·Faisal A Al-AllafMichael Themis
Jul 21, 2007·Journal of Neurosurgery·Seunguk OhJohn R Ohlfest
Aug 28, 2014·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Casey A MaguireXandra O Breakefield
Jul 17, 2012·Human Gene Therapy·Barry J ByrneCathryn S Mah
Sep 12, 2006·Annual Review of Pharmacology and Toxicology·A G de Boer, P J Gaillard
Apr 7, 2004·Médecine sciences : M/S·Alice MeunierMichel Pohl
Jul 9, 2008·Journal of Neuroscience Methods·Annahita KeravalaMichele P Calos
Jul 22, 2008·Experimental Neurology·Dolan SondhiRonald G Crystal
Feb 3, 2005·British Journal of Haematology·Ashok Vellodi
Mar 3, 2004·Mental Retardation and Developmental Disabilities Research Reviews·Mario C RattazziW Ted Brown
Dec 14, 2007·Chembiochem : a European Journal of Chemical Biology·Alice AndreuAndrew D Miller
Sep 28, 2007·The European Journal of Neuroscience·Eva HedlundOle Isacson
Apr 24, 2015·Journal of Biomedical Materials Research. Part a·So-Jung GwakYoon Ha
Oct 7, 2004·Biochimica Et Biophysica Acta·Marc C Patterson, Frances Platt
Aug 27, 2005·The Psychiatric Clinics of North America·Christopher M Filley
Feb 15, 2015·Nanomedicine : Nanotechnology, Biology, and Medicine·Cristina Soto-SánchezEduardo Fernández
Apr 4, 2007·The Journal of the American Dental Association·Peter B LockhartPhilip C Fox
Nov 24, 2007·Experimental Neurology·Kathleen A Maguire-ZeissHoward J Federoff
Apr 20, 2004·Molecular Therapy : the Journal of the American Society of Gene Therapy·Maneesh GuptaK Michael Gibson
Feb 25, 2003·Molecular Therapy : the Journal of the American Society of Gene Therapy·John A OlschowkaHoward J Federoff
Apr 27, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·Marco A PassiniGregory R Stewart
Apr 27, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·Matthias KlugmannMatthew J During
Jan 4, 2003·Nature Reviews. Neuroscience·Robert M Sapolsky
May 6, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Johannes SchwarzHenry A Lester
Dec 23, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Claire SoudaisEric J Kremer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Canavan Disease

Canavan disease, a type of leukodystrophy, is an autosomal recessive neurodegenerative disorder, and is one of the most common degenerative cerebral diseases of infancy. Discover the latest research on Canavan disease here.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.